JP2024531913A5 - - Google Patents
Info
- Publication number
- JP2024531913A5 JP2024531913A5 JP2024506665A JP2024506665A JP2024531913A5 JP 2024531913 A5 JP2024531913 A5 JP 2024531913A5 JP 2024506665 A JP2024506665 A JP 2024506665A JP 2024506665 A JP2024506665 A JP 2024506665A JP 2024531913 A5 JP2024531913 A5 JP 2024531913A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- sequence
- sequence ids
- antigen
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163229134P | 2021-08-04 | 2021-08-04 | |
| US63/229,134 | 2021-08-04 | ||
| PCT/US2022/039302 WO2023014810A2 (en) | 2021-08-04 | 2022-08-03 | Anti-her2 antibodies and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024531913A JP2024531913A (ja) | 2024-09-03 |
| JP2024531913A5 true JP2024531913A5 (https=) | 2025-08-13 |
Family
ID=85156304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024506665A Pending JP2024531913A (ja) | 2021-08-04 | 2022-08-03 | 抗ｈｅｒ２抗体及びそれらの使用 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4380638A4 (https=) |
| JP (1) | JP2024531913A (https=) |
| KR (1) | KR20240040101A (https=) |
| CN (1) | CN117980888A (https=) |
| AU (1) | AU2022324015A1 (https=) |
| CA (1) | CA3228259A1 (https=) |
| WO (1) | WO2023014810A2 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL263466B2 (en) * | 2013-12-17 | 2023-10-01 | Genentech Inc | Anti-CD3 antibodies and methods of using them |
| JP6871155B2 (ja) * | 2014-07-25 | 2021-05-12 | メモリアル スローン ケタリング キャンサー センター | 二重特異性ｈｅｒ２及びｃｄ３結合分子 |
| WO2019034580A1 (en) * | 2017-08-14 | 2019-02-21 | Morphosys Ag | HUMANIZED ANTIBODIES FOR CD3 |
-
2022
- 2022-08-03 CN CN202280064044.3A patent/CN117980888A/zh active Pending
- 2022-08-03 AU AU2022324015A patent/AU2022324015A1/en active Pending
- 2022-08-03 WO PCT/US2022/039302 patent/WO2023014810A2/en not_active Ceased
- 2022-08-03 KR KR1020247006400A patent/KR20240040101A/ko active Pending
- 2022-08-03 CA CA3228259A patent/CA3228259A1/en active Pending
- 2022-08-03 EP EP22853864.1A patent/EP4380638A4/en active Pending
- 2022-08-03 JP JP2024506665A patent/JP2024531913A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Paul et al. | Cancer therapy with antibodies | |
| Tapia-Galisteo et al. | Bi-and trispecific immune cell engagers for immunotherapy of hematological malignancies | |
| CN113166262B (zh) | Pd-1单结构域抗体及其治疗组合物 | |
| Nissim et al. | Historical development of monoclonal antibody therapeutics | |
| JP2023537002A5 (https=) | ||
| RU2017145150A (ru) | Антитело против pdl-1, его фармацевтическая композиция и применение | |
| US20210024630A1 (en) | Guidance and navigation control proteins and method of making and using thereof | |
| IL273484B1 (en) | A33 antibody compositions and methods of using the same in radioimmunotherapy | |
| JP2022541435A5 (https=) | ||
| JP2022546572A5 (https=) | ||
| WO2019234220A1 (en) | Dll3-cd3 bispecific antibodies | |
| WO2015063187A1 (en) | Multivalent antigen-binding proteins | |
| US11787863B2 (en) | Multi-specific antibodies and methods of making and using thereof | |
| JP2022525435A5 (https=) | ||
| JP2019519492A5 (https=) | ||
| JP2022538117A5 (https=) | ||
| JP2020523029A5 (https=) | ||
| JP2020534017A5 (https=) | ||
| KR102291725B1 (ko) | 항-cntn4 항체 및 그의 용도 | |
| JP2024530166A5 (https=) | ||
| JP2023159379A (ja) | Ｐｄ－１とｖｅｇｆを標的とした四価二重特異性抗体、その製造方法および用途 | |
| JP2021517816A5 (https=) | ||
| CN110382533A (zh) | 特异性结合CD66c的抗体及其用途 | |
| CN113150156A (zh) | 抗tigit抗体及其用途 | |
| Holliger et al. | Engineering antibodies for the clinic |